期刊文献+

小鼠肝脏内Mac-1阴性自然杀伤细胞分泌细胞因子能力的研究

Research on cytokine secretory capacity of Mac-1 negative natural killer cell in mouse liver
下载PDF
导出
摘要 目的:研究小鼠肝脏内Mac-1阴性自然杀伤细胞分泌细胞因子的能力。方法:采用poly I:C和IL-2分别在体内和体外激活小鼠肝脏内的NK细胞,采用尼龙毛柱和免疫磁珠分选提纯Mac-1阴性和阳性自然杀伤细胞,用酶联免疫斑点(ELISPOT)法检测IFN-γ、IL-4、IL-5三种细胞因子的分泌情况。结果:Mac-1阴性自然杀伤细胞优势分泌IL-4、IL-5;Mac-1阳性自然杀伤细胞优势分泌IFN-γ。结论:Mac-1阴性自然杀伤细胞属于NK2细胞亚群;Mac-1阳性自然杀伤细胞属于NK1细胞亚群。 Objective:To study the cytokine secretory capacity of Mac-1 negative natural killer cell in mouse liver.Methods:NK cells in mouse liver were activated by poly I:C and IL-2 both in vivo and in vitro.Mac-1 negative and positive natural killier cells were purified with nylon wool and MACS system cell sorting,and secretion of IFN-γ,IL-4 and IL-5 was determined using enzyme-linked immunosorbent Dot(ELISPOT).Results:Mac-1 negative natural killer cells secreted IL-4 and IL-5;and Mac-1 positive natural killer cells produced IFN-γ upon activation.Conclusion:Mac-1 negative natural killer cells are in NK2 cell subsets:whereas Mac-1 positive natural killer cells are in NK1 cell subsets.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第1期44-47,共4页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(No.30671899No.30540012)
关键词 MAC-1 自然杀伤细胞 细胞因子 肝脏 Mac-1 Natural killer cells Cytokines Liver
  • 相关文献

参考文献6

二级参考文献40

  • 1吴霞,李大金,袁敏敏,朱影,王明雁.蜕膜自然杀伤细胞趋化因子受体的表达及募集机制的研究[J].中华医学杂志,2004,84(12):1018-1023. 被引量:5
  • 2Schwartz RH, Jackson L, Paul WE. T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation [ J ]. J Immunol,1975, 115(5): 1 330- 1 338.
  • 3Ross G,Vetvicka V,Thornton B.Analysis of the phagocyte membrane lectin CR3 using fluorescence-labeled polysaccharides and flow cytometry[A].In J Robinson and G Babcock (ed),Inc.Phagocyte function:a guide for research and clinical evaluation[M].New York,John Wiley & Sons,1998:P1-17
  • 4Davenpeck KL,Zagorski J,Schleimer RP,et al.LPS-induced leukocyte rolling and adhesion in the rat mesenteric microsirculation by glucocorticoids and role of cytokine[J].J Immunol,1998,161(12):6861-6870
  • 5Ross GD,Vetvicka V,Yan J,et al.Therapeutic intervention with complement and β-glucan in cancer[J].Immunopharmacology,1999,42(1-3):61-74.
  • 6Harlan JM,Vedder NB,Winn RK,et al.Mechanisms and consequences of leukocyte-endothelial interaction[J].West J Med,1991,155(4):365-369.
  • 7Ross GD.Regulation of the adhesion versus cytotoxic functions of the Mac-1 glycoprotein[J].Crit Rev Immunol,2000,20(3):197-222.
  • 8Vetvicka V,Thornton BP,Wieman TJ,et al.Targeting of NK cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan primed CR3[J].J Immunol,1997,159(2):599-605.
  • 9Hong F,Hansen RD,Yan J,et al.Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells[J].Cancer Res,2003,63(24):9023-9031.
  • 10Yan J,Vetvicka V,Xia Y,et al.β-Glucan,a "specific" biologic response modifier that uses antibodies to target tumors for recognition by complement receptor type 3[J].J Immunol,1999,163(6):3045-3052.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部